Home / Resources (page 544)

Resources

RESOURCES

FDA Puts Empagliflozin on Hold

Quality issues in the manufacturing plant prevents final approval…. The investigational type 2 diabetes drug empagliflozin won’t win the FDA’s approval until “previously observed deficiencies” at a manufacturing plant are fixed, the drug’s sponsors said last week. Eli Lilly and Boehringer Ingelheim said the FDA had issued a complete response …

Read More »

Obesity 2014, Part 5

DCMS178HS

  In this week’s Homerun Slides, we continue our exploration of the current obesity crisis with a discussion of prediabetes, the conditions which can lead to prediabetes including genetic disposition, and the possibility of preventing the onset of diabetes by acting quickly…. 

Read More »